Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
268
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
+1M
-
Total reported value, excl. options
-
$3.8B
-
Value change
-
+$211M
-
Put/Call ratio
-
156.13
-
Number of buys
-
149
-
Number of sells
-
-106
-
Price
-
$199.34
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2017
299 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q1 2017.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
.
Largest 10 shareholders include ATLANTA CAPITAL MANAGEMENT CO L L C (1.75M shares), BlackRock Inc. (1.73M shares), VANGUARD GROUP INC (1.67M shares), ACADIAN ASSET MANAGEMENT LLC (895K shares), Corvex Management LP (847K shares), ARIEL INVESTMENTS, LLC (674K shares), TimesSquare Capital Management, LLC (612K shares), STATE STREET CORP (536K shares), UBS ASSET MANAGEMENT AMERICAS INC (437K shares), and FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ (433K shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.